Large differences in incidence in relation to social class have been observed in developed countries for many tumour sites.`16 These differences can be accounted for in several ways, for example, the differential magnitude of exposures to risk factors in terms of specific agents, such as chemicals in the workplace, or in terms of more general patterns of risk such as diet, tobacco smoking, or reproductive behaviour. As for tumours in which the effectiveness of preclinical diagnosis is recognised (breast and cervical cancers), differences in the incidence of advanced lesions or in mortality could reflect inequalities of access to screening services. Differences in survival are a more complex subject. Since most of the evidence on survival differences comes from cancer registries, which often do not collect information on disease stages, observed differences can be due either to true effects or to artefacts. Among the artefacts one can include:
1. Lead time bias: people from higher social groups may have more prompt access to diagnosis and treatment services, early diagnosis, and therefore lengthening the survival time, even without alteration of the natural history of the disease; 2. Effect of competitive causes of death: social differences in general mortality are well documented in many industrialised countries,7 but it is not always possible to control for these factors by computing relative survival using social class-specific life tables; 3. Confounding: some factors, such as marital status or place of residence, can be correlated to both social status and compliance to treatment, thus playing a confounding role in the analysis of survival; and 4. Casual fluctuations when the number of cases followed up is small.
Social differences in survival can be true effects due to: 1. Delays -diagnostic delay, for example, can result in more advanced stages at presentation and reduce the efficacy of treatment; 2. Restricted access to better treatments; 3. Disparities in the quality of general care (independent of specific treatments); and 4. Inequalities in access to effective screening programmes.
International reports vary widely depending on countries and cancer sites. The excesses in mortality among socially disadvantaged cancer patients compared with those from higher socioeconomic groups are generally higher than 25% in the USA (28%8), while they are lower in the UK (men=20%; women= 12%2), Canada (men= 11%; women=25%9), and Sweden (approximately 10%5). They seem to be higher for cancer sites with a good prognosis, like colon cancer (USA -men=45%, women= 42%10; >200%'; UK -men = 44%, women = 12%2; Sweden -about 27%5) than for cancer sites with a poor prognosis, like lung cancer (USA -men=4%"'; UK -men=8%; women = 13%2; Sweden -no differences5).
Even though no published data on social differences in cancer survival are available for
Italy, and despite the principle of equal access to the national health service, data on social differences in incidence' and mortality" show that access to health services and effective screening programmes can be expected to be influenced by geographical, cultural, and socioeconomic factors, as has been documented in previous studies. 12 -14 In this study, social differences in cancer survival were analysed by using data routinely collected by the Piedmont cancer registry and record linkage with census data which thereby provided individual-based social indicators.
Methods

SUBJECTS
The present analysis was based on recordlinkage between files of the Piedmont cancer registry, which is population based and covers the urban area of Turin (about one million inhabitants), and 1981 census data on Turin residents through the Turin longitudinal study. This procedure, the details of which are published elsewhere,'5 allowed us to characterise by social condition 12 655 subjects (88.3%) from the 14 330 total incident cases reported to the cancer registry during the period 1985-87. 16 The main reasons for linkage failure were as follows: immigration after the census time (5.1 %), errors in residency status (2.1 %), and other causes (4.4%). All subjects were followed up until the end of March 1993 with a minimum follow up period of 5 years and 3 months. Ten cases (0.08%) were lost during follow up.
Cases notified to the cancer registry by means of death certificates only were excluded (635 cases) because it was not possible to trace the exact date of diagnosis and, consequently, to measure their survival time. Subjects less than 25 years old at the time of diagnosis were also excluded because they could not have reached a higher education level and therefore any comparison in relation to level of education would have been biased. Finally, the total number of cases left in the analysis was 11 653.
SOCIAL CLASS INDICATORS
Following Max Weber's theory on social class, based on the multi-dimensionality of the condition involving status, power, and income, the most used indicators of social class are occupation and education.'7 At least in Europe, the best known indicator is occupation, and the most common classification was developed by the Registrar General of England and Wales in 1911, and adapted to the changing structure of the society every 10 years.7 However, scales based on occupation usually do not consider retired or unemployed people, and they classify only a small proportion of women correctly.
Education, at least partly, is a measure of status and income. Some authors prefer to use education, rather than occupation, as a socioeconomic indicator for adults, mainly because the former applies with equal validity to women and inactive men, and it usually does not change during adult life. '8 Italy does not have a generally accepted social classification as in Great Britain. Moreover, in a previous study about social inequalities in cancer risk in Turin, education showed a clearer relationship to the risk of cancer than did occupation.' For these reasons, level of education was used in this analysis as an indicator of social class. Using the available census data, the scale used in this analysis was: university degree (more than 15 years of education); high school (12-14 years); middle school (6-11 years); primary school (fewer than 6 years). Information on housing tenure was considered as an indirect measure of income, dividing subjects into two groups, of roughly the same size, owners and tenants.
ANALYSIS
Case fatality ratios (CFR) were estimated through a proportional hazard model,'9 with socioeconomic indicators as risk factors. The proportionality assumption of models, both graphically and formally, was checked by testing the statistical significance of time-dependent variables.20 Since age was highly correlated with survival time, the lack of proportionality was controlled for by means of stratification into two age groups, and a continuous term for age measured in years was included in models as a confounder. In addition, CFR was adjusted for gender, when appropriate, after having carefully checked and excluded interaction with other risk factors. Since area ofbirth was known as a potential confounder, this factor was also controlled for.
Education and housing tenure were included in models together to take account of the two dimensions of social class as previously defined. Highly educated people had a significantly better survival for all malignant tumours with a linear decrease of risk of dying from 0.91 for people with a middle school education to 0.67 for people with a university degree, compared with those with only primary school level education. The overall figure was influenced by the different behaviour and distribution of cancers in relation to site and social class.
Cancers of the digestive tract, in general, did not show a clear relationship with education. Only when considering cancers of the colon and rectum was there a significant difference in risk, and this favoured those with the highest levels of education.
Respiratory cancers were mainly represented by lung cancer, for which a clear pattern was not present. On the other hand, cancer of the larynx showed a significant decrease in the CFR from lower to higher education.
In gynaecological cancers, education played a less clear role, while in cervical cancer house tenure was significantly associated with a lower 60% survival or more at 3 years were deemed to be cancers with a good prognosis and those which showed 25% survival or less at 1 year were cancers with a worse prognosis. Socioeconomic differences in the risk of dying were generally present in both groups and sexes, but education had a stronger effect on survival for cancer with a good prognosis, particularly in men (table 2) . In contrast, women showed a more evident effect ofsocioeconomic indicators in cancers with a poor prognosis.
Discussion
A 1985-92 mortality follow up of the 1985-87 incidence cancer series of the city of Turin showed significant social differences in survival. People from the lower educational level category showed an excess mortality of about 50% compared with people who had graduated from university. This excess seems higher than that found in other countries (USA -28%'; Canada men =11%, women = 25%9; UK: men = 11 %; women = 26%2). Our data showed that people in lower level education groups were disadvantaged in terms of survival and that this might be explained by differences in access to effective treatments. In particular, figures for men confirm clearly the hypothesis ofinequality in care since the social differences are concentrated in cancers with a good prognosis. Those for women are more complex. Fatality rates for cancers with a good prognosis showed a weaker trend when compared with those in men; in fact 62% of these cases were breast and cervix cancers which have low trends. The survival for poor prognosis cancers among women showed a strong tendency to be higher among more privileged people, in contrast with the figures for men and with the expected profile. This might be due to a lead time effect. That is, high socioeconomic groups would receive a prompter diagnosis than less privileged people -the natural course of the disease does not change, but simply the time since diagnosis increases. Even if it produces a small increase, it becomes relevant when the total survival time is short. If access to treatment plays such an important role in promoting social differences in survival, an effect can be detected for those cancers where cytotoxic treatments are effective such as cancer of the testis, ovary, and some neoplasms of haemopoietic system (in particular Hodgkin's disease)."23 Moreover surgery appears to be effective in colonic, laryngeal, and bladder cancers. In our study, neoplasms of the haemopoietic system and colorectal and laryngeal cancers showed the highest differences in survival, to the detriment if the lower social class. Among sites for which effective treatment exists, only cancer of the ovary did not show a similar profile. On the other hand, treatment for cancer of the ovary is effective only in early stages and in our population patients are not usually seen before the disease is more advanced. Data from Sweden and United Kingdom confirm the Italian profile: high social differences were found for colorectal (USA -170% of excess8; Sweden -27%5; UK -men= 44%, women= 12%2) and bladder cancers (Sweden -7%5; UK -men= 22%, women =41%2), while smaller differences are found for cancer ofthe ovary (Sweden -4%5; UK -14%2).
Early diagnosis can also contribute to the prognostic advantage of the upper classes.23 In Turin, Vines et al'4 found that people from lower social levels had a fivefold increase in the probability of being admitted to hospital treatment with more advanced stages of colorectal cancer than those from the upper levels. In the United Kingdom, stomach cancer showed a 10% excess of mortality among housing tenants compared with owner-ocupiers; the figures for oesophageal cancer for men and women were 11% and 26% respectively and for cancer of the pancreas they were 11 % and 51 % respectively.2 No differences were found in Sweden for pancreatic cancer.5 Even breast cancer, which is expected to be partially influenced by both stage and treatment, showed only a slight indirect correlation of mortality with social class. On the other hand, breast cancer survival data from Sweden and UK showed only slight social differences (Sweden 11% and 2% for the UK).
The case of breast cancer is in some way similar to that of cancer of the cervix uteri. No relevant differences in educational level were 
